EDITORIAL article
Front. Cardiovasc. Med.
Sec. Cardioneurology
Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1670996
This article is part of the Research TopicUpdates on Cardiovascular Variability: Underlying Mechanisms and Non-Pharmacological Therapeutic TargetsView all 7 articles
Editorial: Updates on Cardiovascular Variability: Underlying Mechanisms and Non-Pharmacological Therapeutic Targets
Provisionally accepted- 1University of Milan, Milan, Italy
- 2Universidade de Sao Paulo, São Paulo, Brazil
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The successful translation of heart rate variability (HRV) applications from bench to bedside is largely rooted in the pioneering studies led by Professor Alberto Malliani and his group (1). In essence, a reduction in HRV oscillatory patterns, or an overall loss of cardiovascular variability, reflects disfunction in the modulation of target organ function and serves as a robust prognostic marker (1). Advances in signal processing along with a growing understanding of brain-body interactions, have uncovered new connections between the autonomic nervous system and other biological systems thereby broadening the scope of HRV research. This Research Topic brings together multidisciplinary contributions that advance our understanding of cardiovascular variability across experimental models, novel methodologies, and clinical applications. Our aim was to provide updated perspectives that bridge from basic physiological mechanisms and applied clinical research, ultimately fostering improved diagnostics, risk stratification, and therapeutic monitoring through the lens of cardiovascular variability assessment.The studies included in this collection highlight recent advances in the application of cardiovascular variability assessment across a range of clinical and physiological contexts. Scatà and colleagues reported that postmenopausal women exibit significant reductions in HRV and baroreflex sensitivity compared to age-matched premenopausal controls, pointing to estrogen deficiency in the disruption of autonomic cardiovascular regulation (2). In another study, individuals with long COVID who reported persistent palpitations exhibited altered HRV and baroreflex sensitivity, suggesting that cardiac autonomic imbalance may contribute to the post-acute sequelae of SARS-CoV-2 infection (3). Dos Santos and colleagues (4) demonstrated that HRV indices combined with machine learning techniques can effectively detect both the presence and severity of obstructive sleep apnea, supporting the development of rapid, non-invasive diagnostic tools. Also, in the field of sleep medicine, multifactorial analysis of HRV revealed altered complexity and scaling behavior in healthy pregnant women compared to non-pregnant controls, offering a sensitive method in capturing subtle autonomic changes during gestation (5).Beyond clinical aspects, environmental and physiological stressors also modulate cardiovascular variability. Oliveira and colleagues (6) showed that men and women exhibit distinct autonomic responses to hypoxia: women preserved vagal activity and maintained stable baroreflex function, while men exhibited marked reductions in HRV, suggesting sex-specific autonomic adaptations. In the scenario of space medicine, a shortarm human centrifugation protocol delivering artificial gravity mitigated the decline in baroreflex function and HRV typically observed during prolonged bed rest, highlighting its potential as a countermeasure against cardiovascular deconditioning in microgravity simulations (7).Together, these studies underscore the multifaceted relevance of cardiovascular variability as both a physiological marker and a clinical tool. They highlight the interplay between the autonomic nervous system, clinical features, and the environment influences.As new technologies and analytical frameworks continue to evolve, variability-based metrics are poised to play an increasingly prominent role in personalized medicine, enabling more precise diagnostics and targeted interventions. We hope this Research Topic will inspire continued interdisciplinary collaboration and innovation in the study of cardiovascular variability.
Keywords: Autonomic Nerovus System, Baroreflex sensitivity (BRS), machine learning (ML), microgravity, hypoxia, Long Covid, Menopause
Received: 22 Jul 2025; Accepted: 04 Aug 2025.
Copyright: © 2025 Dias Rodrigues, Fazan Jr. and Montano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Gabriel Dias Rodrigues, University of Milan, Milan, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.